SPONSOR
Hansoh BioMedical R&D Company
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 1
Conditions studied: Moderate-to-severe Plaque PsoriasisAdvanced Solid TumorsHead and Neck Squamous Cell Carcinoma
Hansoh BioMedical R&D Company is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Moderate-to-severe Plaque Psoriasis, Advanced Solid Tumors, Head and Neck Squamous Cell Carcinoma.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hansoh BioMedical R&D Company
How many clinical trials has Hansoh BioMedical R&D Company sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Hansoh BioMedical R&D Company, of which 3 are actively recruiting participants. These trials cover conditions including Moderate-to-severe Plaque Psoriasis, Advanced Solid Tumors, Head and Neck Squamous Cell Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hansoh BioMedical R&D Company research focus on?
Hansoh BioMedical R&D Company clinical trials span Moderate-to-severe Plaque Psoriasis, Advanced Solid Tumors, Head and Neck Squamous Cell Carcinoma. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hansoh BioMedical R&D Company clinical trial?
To participate in a Hansoh BioMedical R&D Company trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hansoh BioMedical R&D Company trials with current recruitment status updated daily.
Clinical Trials by Hansoh BioMedical R&D Company
NCT07879885 Phase 2
Recruiting
An Open-label Study of HS-20137 in Participants With Moderate-to-Severe Plaque Psoriasis
Moderate-to-severe Plaque Psoriasis
NCT07186452 Phase 1
Recruiting
Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
NCT06007729 Phase 2
Recruiting
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Head and Neck Squamous Cell Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology